Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Klebsiella pneumoniae D-ribose pyranase (rbsD) CSB-YP475446KBH
CSB-EP475446KBH
CSB-BP475446KBH
CSB-MP475446KBH
CSB-EP475446KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae ATP synthase subunit c (atpE), partial CSB-YP475447KBH1
CSB-EP475447KBH1
CSB-BP475447KBH1
CSB-MP475447KBH1
CSB-EP475447KBH1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Multidrug resistance protein MdtL (mdtL), partial CSB-YP475448KBH
CSB-EP475448KBH
CSB-BP475448KBH
CSB-MP475448KBH
CSB-EP475448KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Ribonuclease P protein component (rnpA) CSB-YP475449KBH
CSB-EP475449KBH
CSB-BP475449KBH
CSB-MP475449KBH
CSB-EP475449KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Adenylate kinase (adk) CSB-YP475450KBH
CSB-EP475450KBH
CSB-BP475450KBH
CSB-MP475450KBH
CSB-EP475450KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae UPF0133 protein KPK_4227 (KPK_4227) CSB-YP475451KBH
CSB-EP475451KBH
CSB-BP475451KBH
CSB-MP475451KBH
CSB-EP475451KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae ATP-dependent Clp protease ATP-binding subunit ClpX (clpX) CSB-YP475452KBH
CSB-EP475452KBH
CSB-BP475452KBH
CSB-MP475452KBH
CSB-EP475452KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae 6,7-dimethyl-8-ribityllumazine synthase (ribH) CSB-YP475453KBH
CSB-EP475453KBH
CSB-BP475453KBH
CSB-MP475453KBH
CSB-EP475453KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Probable HTH-type transcriptional regulator matA homolog (matA) CSB-YP475454KBH
CSB-EP475454KBH
CSB-BP475454KBH
CSB-MP475454KBH
CSB-EP475454KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Na (+)-translocating NADH-quinone reductase subunit A CSB-YP475455KBH
CSB-EP475455KBH
CSB-BP475455KBH
CSB-MP475455KBH
CSB-EP475455KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Proline--tRNA ligase (proS), partial CSB-YP475456KBH
CSB-EP475456KBH
CSB-BP475456KBH
CSB-MP475456KBH
CSB-EP475456KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Sugar fermentation stimulation protein homolog (sfsA) CSB-YP475457KBH
CSB-EP475457KBH
CSB-BP475457KBH
CSB-MP475457KBH
CSB-EP475457KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae UDP-3-O-acyl-N-acetylglucosamine deacetylase (lpxC) CSB-YP475458KBH
CSB-BP475458KBH
CSB-MP475458KBH
CSB-EP475458KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Ribosomal RNA small subunit methyltransferase H (rsmH) CSB-YP475459KBH
CSB-EP475459KBH
CSB-BP475459KBH
CSB-MP475459KBH
CSB-EP475459KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae 3-dehydroquinate dehydratase (aroD) CSB-YP475460KBH
CSB-EP475460KBH
CSB-BP475460KBH
CSB-MP475460KBH
CSB-EP475460KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Ribosomal RNA small subunit methyltransferase A (rsmA) CSB-YP475461KBH
CSB-EP475461KBH
CSB-BP475461KBH
CSB-MP475461KBH
CSB-EP475461KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Citrate lyase acyl carrier protein (citD) CSB-YP475462KBH
CSB-EP475462KBH
CSB-BP475462KBH
CSB-MP475462KBH
CSB-EP475462KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Trp operon repressor (trpR) CSB-YP475463KBH
CSB-EP475463KBH
CSB-BP475463KBH
CSB-MP475463KBH
CSB-EP475463KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae UPF0442 protein KPK_4801 (KPK_4801), partial CSB-YP475464KBH1
CSB-EP475464KBH1
CSB-BP475464KBH1
CSB-MP475464KBH1
CSB-EP475464KBH1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Aspartate carbamoyltransferase (pyrB) CSB-YP475465KBH
CSB-EP475465KBH
CSB-BP475465KBH
CSB-MP475465KBH
CSB-EP475465KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>